A study is set to explore if artificial intelligence (AI) can help doctors make better decisions when it comes to treating prostate cancer. While prostate cancer diagnosis has become safer and more ...

In daily pediatric practice, shared decision-making is already happening, often more than is acknowledged,” a pediatrician ...

—A recent analysis showed that health concerns, rather than costs, influenced treatment strategies in commercially insured men with prostate cancer. Among men with newly diagnosed prostate cancer, ...

The Urology Care Foundation is working to create new resources to provide support, hope and guidance to prostate cancer ...

Angela Jia, MD, PhD, is a radiation oncologist specializing in stereotactic body radiation therapy (SBRT), adaptive radiotherapy, and clinical trials focused on prostate, bladder, and kidney cancers.

Prostate cancer is the second-leading cause of cancer death in American men. About 1 in 8 men will be diagnosed with prostate cancer in their lifetime, and the risk varies depending on age and race.

FDA-authorized AI tools have the potential to help patients with prostate cancer get clearer answers instead of waiting weeks for genomic test results. FDA-authorized artificial intelligence (AI) ...

A Northwestern University-led study in the emerging field of nanocytology could one day help men make better decisions about whether or not to undergo aggressive prostate cancer treatments. Technology ...

University Hospitals Seidman Cancer Center researchers have developed a tool that could identify metastatic prostate cancer earlier. This tool may help guide treatment, such as signalling when to ...

Decades ago, doctors created a test to determine which breast cancer patients should receive hormone therapy. Now, ...

In a statement, NICE said the new guidance for Talzenna will make it an option for around 2,400 people in England and reduce ...